Cord Blood Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseFetal BloodBone MarrowTransplantation, AutologousHematopoietic Stem Cell TransplantationWhole-Body IrradiationBone Marrow CellsTransplantation ConditioningLeukemiaAnemia, AplasticTransplantation ChimeraHematopoietic Stem CellsBusulfanTissue DonorsGraft SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHistocompatibility TestingRecurrenceMonocrotophosGraft vs Tumor EffectLeukocyte TransfusionHematologic NeoplasmsHistocompatibilityCyclophosphamideRemission InductionLeukemia, Myeloid, AcutePeripheral Blood Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Leukemia EffectRadiation ChimeraLymphocyte DepletionStem CellsGraft vs Host ReactionAntigens, CD34Transplantation, IsogeneicPenile ImplantationCombined Modality TherapyAcute DiseaseT-LymphocytesImmunosuppressive AgentsTreatment OutcomeBlood BanksBone Marrow PurgingHepatic Veno-Occlusive DiseaseLeukemia, MyeloidLymphocyte TransfusionMice, Inbred C57BLTime FactorsHematopoiesisBone and BonesImmunosuppressionSpinal CordChimeraMyelodysplastic SyndromesTransplantation ImmunologyNuclear FamilyStem Cell TransplantationCyclosporineGraft RejectionHLA AntigensSurvival AnalysisGranulocyte Colony-Stimulating FactorRetrospective StudiesLiver TransplantationCell DifferentiationCytomegalovirus InfectionsHematologic DiseasesLymphoma, Non-HodgkinCells, CulturedActuarial AnalysisFatal OutcomeMice, Inbred BALB CAntineoplastic Combined Chemotherapy ProtocolsCytarabineSurvival RateHematopoietic Stem Cell MobilizationSevere Combined ImmunodeficiencyFollow-Up StudiesFlow CytometryBone Marrow DiseasesDisease-Free SurvivalMultiple MyelomaImmunophenotypingSpinal Cord InjuriesColony-Forming Units AssayLeukocyte CountSpleenEtoposideInfectionMice, SCIDAntigens, CDLymphocyte Culture Test, MixedLymphocyte ActivationLymphomaPancytopeniaKidney TransplantationCell Separation